Abstract: The invention relates to the use of tryptophane-derivatives for the specific cytostatic treatment of serotonin-producing tumors, such as, for example carcinoids and the like. Areas of application of the invention are in the field of medicine and pharmaceutical industry.

Abstract: An electrical switch having a form of one of a joystick and a cursor switch is provided, including an operating element. The operating element interacts with at least one of rotation means such that the operating element can be rotated, and with movement means such that the operating element can be moved in at least one linear direction on a movement plane. The operating element has a switching effect on a switching element during rotation and/or during movement.

Abstract: The present invention relates to novel, specifically neuronal expressed proteins with tryptophane hydroxylase activity, nucleic acid sequences, recombinant nucleic acid molecules containing these nucleic acid sequences or vectors containing these nucleic acid sequences or the recombinant nucleic acid molecules encoding for a neuronal tryptophane hydroxylase. The invention also relates to transgenic organisms containing these nucleic acid sequences, the recombinant nucleic acid molecules or the above cited vectors. The invention moreover refers to mono- or polyclonal antibodies directed against the isolated proteins. Furthermore, the invention relates to the use of these nucleic acid sequences and proteins for diagnosis, predisposition, therapy and monitoring of neuronal diseases. Possible fields of application among others are medicine and the pharmaceutical industry.

Abstract: An electrical switch having a form of one of a joystick and a cursor switch is provided, including an operating element. The operating element interacts with at least one of rotation means such that the operating element can be rotated, and with movement means such that the operating element can be moved in at least one linear direction on a movement plane. The operating element has a switching effect on a switching element during rotation and/or during movement.

Abstract: Pharmaceutical compositions for treatment of primary hemostasis deficiency and methods of treatment of primary hemostasis deficiency are disclosed. Also, methods for diagnosing neuronal diseases and for suppressing the immune system are disclosed. Isoforms responsible for maintaining primary hemostasis, T-cell mediated immune responses, neuron specific TPH, and a neuronal tryptophan hydroxylase are disclosed.

Abstract: Multi-layer films that are suitable for packaging and having improved sealing properties are disclosed. Some embodiments may also provide a lower minimum sealing temperature. A soft polymer is blended in a core layer and a tie layer comprising the soft polymer and, optionally, another polymer. A sealable layer is provided on the side of the tie layer opposite the core layer. The multi-layer films may be transparent, contain a cavitating agent, or are pigmented to form an opaque film. Also, the multi-layer film may be metallized or coated with a barrier coating.

Abstract: The invention relates to the use of cells from cell lines, which are derived from early embryonic stages, for the donor-specific increase in transplantation tolerance and for repairing damaged tissue. Areas of application of the invention include the field of medicine and the pharmaceutical industry. The aim of the invention is to produce a donor-specific immunotolerance in order to prevent a rejection of the transplanted tissue due to an immune response and thus to be able to limit the administration of immune suppressive agents. In order to produce a donor-specific immunotolerance, embryonic stem cell-like cell lines (ECL) are obtained from blastocysts and are transfected with genetic material of the donor, which codes for the MHC haplotypes. The cells produced in such a manner are administered to the recipient before the transplantation for producing an immunotolerance against the tissue to be transplanted or for regenerating already damaged tissue.

Abstract: The invention relates to the use of tryptophane-derivatives for the specific cytostatic treatment of serotonin-producing tumors, such as, for example carcinoids and the like. Areas of application of the invention are in the field of medicine and pharmaceutical industry.

Abstract: The invention relates to a method for diagnosing neuronal diseases and for treating primary hemostasis deficiency. The invention further relates to a method for suppressing the immune system, which is inter alia significant for transplantation medicine and for the treatment of allergies. The invention is used in the field of medicine and in the pharmaceutical industry. The invention is worked according to the claims. The invention is based on the discovery that serotonin is synthesized by TPH isoenzymes that are differently expressed in the neurons in the peripheral tissues. Gene targeting was used to show that an isoform, the peripheral enzyme (referred to in the following as TPH), is responsible for maintaining primary hemostasis and T-cell mediated immune responses. Another isoform, the newly identified neuron-specific TPH (referred to as nTPH) synthesizes serotonin irrespective thereof in the central nervous system.

Abstract: A shock absorbing fixture for attachment to a device for aiding a user in walking such as a crutch. The fixture comprises a frame with a spring disposed within the frame that compresses under the weight of the user. The fixture is attached to the lower end of the device. The fixture reduces the shock on the user during use of the device. The device also has the capacity to be operated so that the crutch performs as a rigid crutch.